Archive for the ‘BVI Company Joint Ventures’ Category

AgeX Therapeutics and its BVI-registered investor Juvenescence Ltd. announced publication of paper on the engineering of universal cells

Saturday, November 2nd, 2019

Juvenescence Ltd., BVI-registered science company developing technologies to treat aging, and AgeX Therapeutics, Inc., a biotechnology company developing therapeutics for human aging and regeneration, announced the publication of a new paper in the scientific journal Regenerative Medicine. The published paper is on the strategies of engineering of allogeneic cells to be hypoimmunogenic (universal), so as not to produce an immune response. Also, the paper presents previously unpublished observation in vivo on allogeneic human stem cells (hPSCs).

The leading author of the paper is Dr. Nafees Malik, Chief Operating Officer at AgeX and Head of Cell & Gene Therapy at Juvenescence, which is a major investor in AgeX. His co-authors on the paper are Gregory Bailey, MD, Chairman of the Board of Directors of AgeX and CEO of Juvenescence; Annalisa Jenkins, MBBS, FRCP, who serves on the Board of Directors of AgeX; and Jim Mellon, Chairman of Juvenescence.

Dr Malik said in his comments on the publication: “This is a huge area of focus for us at AgeX, via our UniverCyte technology platform. In support of our own research and as a service to the overall field, we decided to put together this paper, analyzing all the leading strategies to engineer universal cells and encapsulating them in one paper.”

Origin Agritech signed agreement with Biotechnology Research Institute

Friday, August 30th, 2019

Origin Agritech Ltd. has entered into a collaboration agreement with Biotechnology Research Institute (BRI) of Chinese Academy of Agricultural Sciences (CAAS), which will speed up the commercialization of genetically modified insect resistance and glyphosate tolerance corn traits in China.

During long time, the BVI corporation has been cooperating with CAAS to develop various GM traits, and the new agreement enhances the cooperation with BRI, mainly focusing on related research for commercialization of the double stacked corn trait of insect resistance and glyphosate tolerance.

Origin and BRI will join together to apply for government sponsored funds and share research facilities and capabilities. Both companies will also work together to promote the commercialization of the stacked corn trait, which Origin has been developing based on the fundamental research from CAAS.

Chinese Academy of Agricultural Sciences is a national, integrative agricultural scientific research organization in China carrying out both basic and applied research, and research into new agriculture technologies. BRI of CAAS is the only public, non-profit institution focusing on the basic and applied research of agro-biotechnology in China.

Origin Agritech entered into investment agreement to form a new JV

Friday, June 7th, 2019

Origin Agritech Ltd., an agriculture technology and rural e-commerce company registered in the British Virgin Islands, entered into a Cooperation Framework Agreement with Beijing Changping Technology Innodevelop Group (BC-TID), with the purpose to form a new joint venture which will be focused on the commercialization of genetically modified corn seed technologies.

According to this agreement, both companies will establish the new entity with approximately equal partnership. BC-TID will fund the joint venture with a total amount of RMB204mln, while Origin Agritech will contribute the Origin Life Science Center building in Beijing and two biotech corn traits – the glyphosate tolerance (Gt) trait and the double stacked traits of insect resistance (Bt) and Gt genes.

These two biotech traits have completed multi-year production tests, and the BVI corporation has already submitted the application for the final stage of biosafety approval to China’s Ministry of Agriculture.

Since Origin started its corn seed biotechnology research 15 years ago in cooperation with Chinese Academy of Agricultural Sciences, it has developed several corn seed biotech traits. Also, the BVI company has entered into commercialization agreements with multinational and local corn seed companies. Dr. Gengchen Han, Origin’s Chairman and Chief Executive Officer, stated: “The investment of BC-TID to form a joint venture for biotech corn seed commercialization gives us very strong support as we’re moving closer to the commercialization of our corn seed biotechnologies.”

BVI company entered into agreement with Port of Québec to develop new terminal

Thursday, May 30th, 2019

Hutchison Port Holdings Ltd., the world’s leading port network, and Canadian National Railway (CN), the leading North American transportation and supply chain company, signed a long term agreement with the Québec Port Authority (QPA) to build and operate the new container terminal project Laurentia, previously known as Beauport 2020.

With this agreement, BVI company’s global network will increase to 52 ports covering 27 countries, including the United Kingdom, Spain, Poland, Sweden, Germany, the Netherlands, Belgium and many others. The project, which is US$775mln worth, will be financed mainly through the joint investment of the three partners.

The QPA has chosen Hutchison Ports after a competitive process in which it invited leading international port operators to provide proposals for the project. The Hutchison Ports is supposed to build the most environmentally and technologically advanced cargo-handling facility in North America.

Group Managing Director of Hutchison Ports said in his comments: “We are pleased to partner with the Québec Port Authority and CN to develop the Québec container terminal. Québec City will become Hutchison Ports’ gateway to the East coast of North America. With its fully intermodal deep-water port, its strategic location to reach the Midwest market, and the strong support shown by the local authorities, the Québec project has all the attributes to be successful in this highly important market.”